CircKat6b通过调节星球细胞功能的调节来调节素的抗抑郁作用
Na Hu1,2, Yujie Zheng1,2, Xueru Liu1,2
1Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
Molecular neurobiology
|August 14, 2024
概括
埃斯凯特胺可以降低星球细胞中的循环RNA Kat6b (circKat6b),缓解抑郁症. 过度表达 circKat6b 阻碍了埃斯基坦胺的产生.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环RNAs (circRNAs) 越来越多地被认为是它们在中枢神经系统中的作用.
- 循环RNAs的失调与抑郁症的发病有关.
- 循环RNAs为抑郁症提供潜在的治疗点.
研究的目的:
- 调查circKat6b在esketamine抗抑郁作用中的作用和机制.
- 为了阐明circKat6b如何影响抑郁症模型中的天体细胞功能.
主要方法:
- 慢性不可预测的轻度压力 (CUMS) 抑郁症的小鼠模型.
- 通过静脉注射使用埃斯基坦胺.
- RNA测序,RT-PCR和西部斑点分析.
- 在海马星球细胞中评估cirKat6b和STAT1/p-STAT1表达.
主要成果:
- 在CUMS小鼠的海马星球细胞中,sketamine治疗降低了circKat6b的表达.
- 过度表达circKat6b减弱了胺胺的抗抑郁作用.
- circKat6b过度表达上调了星细胞中的STAT1和p-STAT1表达.
- 在CUMS小鼠中,cirKat6b过度表达逆转了胺诱导的p-STAT1.1.的下调.
结论:
- 素的抗抑郁作用可能包括降低海马体天体细胞中circKat6b的表达.
- 该机制可能涉及STAT1/p-STAT1信号通路的调制.
- circKat6b代表了一种新的抑郁症治疗点.
更多相关视频
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
1.1K
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
3.3K
相关概念视频
Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
